The Anti-dementia Drug Candidate, (-)-Clausenamide, Improves Memory Impairment through its Multi-target Effect. Chu S, Liu S, Duan W, Cheng Y, Jiang X, Zhu C, Tang K, Wang R, Xu L, Wang X, et al. Pharmacol Ther. 2016 Jan 23. PMID: 26812265. Abstract CommentRecommendBookmarkWatch
